抗特尔比纳类型VII的Trichophyton mentagrophytes:一种新兴的性传播性皮肤植物病
Mouna Korbi1, Maissa Abid1, Sameh Belgacem2,3
1Dermatology Department, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia.
International journal of STD & AIDS
|March 16, 2026
概括
一种新的性传播真菌感染,Trichophyton mentagrophytes基因型VII (TMVII),导致难以治疗的生殖器病变. 这种病例显示出对特尔比纳的耐药性,突出显示出需要分子诊断和像伊特拉可纳这样的替代治疗方法.
科学领域:
- 皮肤病学 皮肤病学
- 菌类学 菌类学是指菌类学.
- 传染性疾病 传染性疾病
背景情况:
- 性传播性皮肤植物病是一种新兴的临床实体.
- 特里科菲顿 (Trichophyton mentagrophytes) 基因型VII (TMVII) 是一种新型致病原体,导致生殖器炎症病变.
- 抗真菌耐药性的增加带来了诊断和治疗方面的挑战.
研究的目的:
- 在异性恋女性中报告一例因特尔比纳耐药TMVII引起的生殖器皮肤植物病例.
- 强调在耐火性生殖器皮肤植物病例中考虑TMVII的重要性.
- 强调需要分子确认和适当的治疗策略.
主要方法:
- 一个35岁的女性生殖器病变的案例报告.
- 临床检查,直接显微镜和真菌培养用于识别.
- 分子分析 (PCR测序) 用于基因型确认.
- 抗真菌敏感性测试和治疗干预.
主要成果:
- 患者呈现出不对局部抗真菌药物反应的性生殖器病变.
- 通过分子分析确定并确认了Trichophyton mentagrophytes VII 基因型.
- 隔离物显示对特尔比纳的耐药性.
- 口服伊特拉科纳导致了完全的临床解决.
结论:
- 这一案例说明了新出现的性传染性皮肤植物病,原因是耐特比纳的TMVII,之前没有与土耳其旅行有关的报告.
- 早期识别,分子确认和适当的治疗对于管理TMVII感染至关重要.
- 有效的合作伙伴管理对于防止这种新出现的病原体进一步传播至关重要.
更多相关视频
07:21Author Spotlight: Unraveling the Interplay Between Trichoderma stromaticum and the Mammalian Immune System
Published on: October 20, 2023
1.8K
05:08Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
1.3K
相关概念视频
Skin Diseases and Disorders
5.4K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.4K
Sexually Transmitted Infections
2.0K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
2.0K
Fungal Phylum Microsporidia
787
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
787
Diversity of Protists I
2.3K
Excavata is a diverse group of protists that includes both chemoorganotrophic and phototrophic species, with some thriving in anaerobic environments. Among the key groups within Excavata are diplomonads and parabasalids, which are flagellated protists that lack mitochondria and chloroplasts. These microorganisms typically inhabit anoxic environments, such as the intestines of animals, where they exist either symbiotically or as parasites, relying on fermentation for energy production. Some...
2.3K
Antifungal Agents
131
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
131
Anthelminthic Agents
115
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
115
